Posts tagged as:
Millions of girls in developing nations will avoid getting a deadly form of cancer—cervical cancer—due to a major drop in costs for two vaccines against cervical cancer. Merck and GlaxoSmithKline announced May 9 that costs for the vaccines against human papillomavirus (HPV) would be cut to below $5 per dose. Over 275,000 women die [...]
{ 0 comments }
We know what works to save the lives of children under five years old: We know which antibiotic to give for treating pneumonia, for example. Yet only 31% of children with suspected pneumonia receive antibiotics. And two million children die from pneumonia and diarrhea each year. The first-ever simultaneous effort to protect children from pneumonia [...]
{ 1 comment }
Mildred Fernando lives and works in the Philippines for the USAID-funded, MSH-led, Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Mildred spoke at several World TB Day events in Washington, DC, including at a senate briefing and an event honoring TB survivors and advocates (watch video). The interview below first appeared on [...]
{ 0 comments }
The state of tuberculosis (TB) is in a tug-of-war as current challenges threaten to undo past successes. One of the primary hurdles currently facing TB prevention and cure is the emergence of strains that are resistant to at least two of the most effective medicines (rifampicin and isoniazid). So-called drug-resistant (DR)-TB arises when patients [...]
{ 0 comments }
Stop TB in my lifetime. This global call to action—the Stop TB Partnership’s theme for March 24, World TB Day 2013—is as relevant now as it was over a hundred years ago. Progress toward reducing the global burden of tuberculosis (TB) has been impressive in recent years: TB mortality has fallen by 41 percent [...]
{ 2 comments }
Formally launched in 2012 in Cameroon, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, led by Management Sciences for Health, has been working on strengthening the overall pharmaceutical management system, specifically to ensure the people of Cameroon have access to safe and affordable medicines at the central and peripheral levels. In [...]
{ 0 comments }
“We’re going to try to drive through that?” After spending nearly two years working in South Sudan, I was on my way with two colleagues to one final meeting. The USAID-funded second phase of the Sudan Health Transformation Project (SHTP II), led by Management Sciences for Health (MSH), ended activities on July 31, 2012, and [...]
{ 5 comments }
“Kwa dawa ya TB ni lazima utembee mpaka upate (You should never give up when searching for anti-TB medicines).” This is the advice that Esther Wahome, a registered community health nurse in a Kenyan health facility, gives to her clients when they come to the tuberculosis (TB) clinic. Within a short time, Esther dispenses the [...]
{ 3 comments }
Crossposted on Maternal Health Taskforce’s mhtfblog as part of the Maternal Health Commodities Blog Series. Despite a decade of significant progress reducing maternal mortality rates, very few countries are on target to meet Millennium Development Goal #5a of reducing the maternal mortality ratio by three-quarters by 2015. What is most alarming is that a large proportion of maternal [...]
{ 1 comment }
Cross-posted on USAID’s IMPACT blog My most vivid early childhood memory is waking up to excruciating pain in my throat, and seeing the goldfish swimming in the aquarium of the pediatric surgical ward. Although penicillin had been discovered 30 years earlier, doctors had not learned yet that treating “strep throats” with penicillin was better than [...]
{ 5 comments }
